Showing results (71-80 of 7,432) with videos related to
Sort By:
Pageof 744
Psychopharmacology|August 26, 1998
The behavioural effects of corticotropin-releasing factor-related peptides in ratsD N Jones, R Kortekaas, P D Slade, et al.European Journal of Pharmacology|March 24, 1992
An investigation of the 5-HT1D receptor binding affinity of 5-hydroxytryptamine, 5-carboxyamidotryptamine and sumatriptan in the central nervous system of seven speciesM S Beer, J A Stanton, Y Bevan, et al.European Journal of Pharmacology|May 8, 1981
Supersensitivity of nigral serotonin receptors and rat rotational behaviourT P Blackburn, B Cox, C G Heapy, et al.Bioresource Technology|June 28, 2011
Evaluation of three composting systems for the management of spent coffee groundsK Liu, G W PriceWaste Management (New York, N.Y.)|January 24, 2024
A review of the influence of heat drying, alkaline treatment, and composting on biosolids characteristics and their impacts on nitrogen dynamics in biosolids-amended soilsQianhan Le, G W PriceNeuropharmacology|March 1, 1993
Stereoselective actions of the isomers of metitepine at 5-HT1D receptors in the guinea pig brainL O Wilkinson, L M Hawkins, M S Beer, et al.Journal of Neuroscience Methods|November 1, 1991
Destruction of a sub-population of cortical neurones by suicide transport of volkensin, a lectin from Adenia volkensiiM N Pangalos, P T Francis, R C Pearson, et al.Journal of Medicinal Chemistry|May 9, 1998
The selective 5-HT1B receptor inverse agonist 1'-methyl-5-[[2'-methyl-4'-(5-methyl-1,2, 4-oxadiazol-3-yl)biphenyl-4-yl]carbonyl]-2,3,6,7-tetrahydro- spiro[furo[2,3-f]indole-3,4'-piperidine] (SB-224289) potently blocks terminal 5-HT autoreceptor function both in vitro and in vivoL M Gaster, F E Blaney, S Davies, et al.British Journal of Pharmacology|May 24, 2000
Characterization of SB-269970-A, a selective 5-HT(7) receptor antagonistJ J Hagan, G W Price, P Jeffrey, et al.Journal of Medicinal Chemistry|June 1, 1988
Graphics computer-aided receptor mapping as a predictive tool for drug design: development of potent, selective, and stereospecific ligands for the 5-HT1A receptorM F Hibert, M W Gittos, D N Middlemiss, et al.Pageof 744